Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.
about
Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in ratsRole of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An UpdateCoronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammationRole of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats.Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemiaAcid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthaseNADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemiaAcid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice.Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytesEpithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemiaTangzhiqing Granules Alleviate Podocyte Epithelial-Mesenchymal Transition in Kidney of Diabetic RatsNADPH oxidases: an overview from structure to innate immunity-associated pathologies.Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice.The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury.Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.PKC/NADPH oxidase are involved in the protective effect of pioglitazone in high homocysteine-induced paracrine dyfunction in endothelial progenitor cells.Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes.MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation.MDM2 Contributes to High Glucose-Induced Glomerular Mesangial Cell Proliferation and Extracellular Matrix Accumulation via Notch1NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801.Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species.NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.
P2860
Q21559663-DF2D7404-6E3F-4906-840B-AF8860276B3EQ28074668-9B3EFDF6-748E-4242-A6B1-2CC6E1F7DB62Q30641163-98877DE4-458B-4CAC-870B-F71087310CE4Q34128783-C61AF41C-4F9C-4F4B-A6A9-3496577159C4Q34222583-52F57B1A-A451-43B0-AAEB-B5C7DE897205Q34245112-B082DA12-947B-4733-8C3E-0E5720FDC54BQ34425178-E0C4F459-989F-421B-AB4F-FD697F9A1431Q35193553-0825C56D-D9EE-4EDC-AD17-0554C6B351E4Q35474438-BE349AD3-C593-4A97-8C1A-74E1F97FEC23Q35486035-E25B30C9-97F4-4D9A-A76C-88F0D1BECAA8Q35564803-46B49AFF-BD00-4DE9-9392-415EE33804CBQ35821693-F6C5DC43-4D86-417B-830C-6B567B7DA34CQ36271095-1156FFAD-2283-49A7-9E60-7FBF99A6751FQ36302873-A85051CA-584D-4DDA-9C10-F10F07BC7E2BQ36328309-218A2AF1-9C66-40EF-89CA-86171EF90F4CQ36545412-FB52D60A-79C9-4FC8-AC45-8EFC0C6165CBQ36731427-69DE2C27-C2FF-4189-9363-88FCD6900EEAQ36803722-51F28D37-2EEB-4EE0-AFA4-D30DE46DFD0CQ36844159-AEEAB439-76C7-44A5-AFA0-F7D1266B77E7Q36894381-D78422BB-FE62-4DC8-B1C4-2D28F0E21F16Q37351517-EED67D70-79C5-48C8-9BAE-A0EEDA8A1F7AQ37622159-663923E9-6AA3-41E0-81C1-86BEA7E32CCAQ37732972-DDF99D54-89B5-48DC-9B83-D3D90B1FA937Q39618941-6707EB91-7172-4FA5-A1B2-237B5DE984BBQ41479502-D718A18D-259F-442C-86EA-B1946F321075Q41605810-FFEB4F82-745F-4E74-8BC7-BF7626542051Q41640119-A6EB5237-99BD-4844-B497-C122B2E1235FQ43552370-2446BEFA-BFDF-403C-96AB-3EC33C4DFA64Q45057004-8AB24240-D409-42A6-A1C9-7383C9F7A540Q45072496-7A27E73E-C44A-492F-AE21-B66510AD4036
P2860
Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protection of podocytes from h ...... deletion of the gp91phox gene.
@ast
Protection of podocytes from h ...... deletion of the gp91phox gene.
@en
type
label
Protection of podocytes from h ...... deletion of the gp91phox gene.
@ast
Protection of podocytes from h ...... deletion of the gp91phox gene.
@en
prefLabel
Protection of podocytes from h ...... deletion of the gp91phox gene.
@ast
Protection of podocytes from h ...... deletion of the gp91phox gene.
@en
P2093
P2860
P1476
Protection of podocytes from h ...... deletion of the gp91phox gene.
@en
P2093
Christopher A Brimson
Chun Zhang
Jun-Jun Hu
Krishna M Boini
Laura A Laperle
Pin-Lan Li
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.01.029
P577
2010-01-29T00:00:00Z